Tuberous Sclerosis Complex (TSC) Report 2018 - Market Insights, Epidemiology and Market Forecast, 2027 - ResearchAndMarkets.com

DUBLIN--()--The "Tuberous Sclerosis Complex (TSC) - Market Insights, Epidemiology and Market Forecast-2027" drug pipelines has been added to ResearchAndMarkets.com's offering.

The market of Tuberous Sclerosis Complex (TSC) in 7MM was found to be USD 372 million in 2016.

Tuberous Sclerosis Complex (TSC) - Market Insights, Epidemiology and Market Forecast-2027 report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of TSC in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

The Report provides the current treatment practices, emerging drugs having the potential to get launched in the forecast period, market share of the individual therapies, current and forecasted market size of Tuberous Sclerosis Complex (TSC) from 2016 to 2027 segmented by seven major markets. The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.

Key Topics Covered:

1. Key Insights

2. Tuberous Sclerosis Complex (TSC) Market Overview at a Glance

3. Disease Overview: Tuberous Sclerosis Complex (TSC)

4. Epidemiology and Patient Population

5. 7MM Total Prevalent Patient Population of Tuberous Sclerosis Complex

6. Country Wise-Epidemiology of Tuberous Sclerosis Complex

7. Current Treatment Practices

8. Unmet Needs

9. Marketed drugs

10. Emerging Therapies

11. Tuberous Sclerosis Complex: 7 Major Market Analysis

12. Market Outlook by Country

13. The United States: Market Outlook

14. EU-5 Countries: Market Outlook

15. Market Drivers

16. Market Barriers

17. Appendix

Companies Mentioned

  • Novartis Pharmaceuticals
  • Nobelpharma Co., Ltd
  • GW Pharmaceuticals
  • Takeda Pharmaceutical Company Limited

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/35fksq/tuberous?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs